LIVN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.01% compare to its pairs and should correct upwards.

Stats
Today's Volume	396 555
Average Volume	665 037
Market Cap	2.95B
EPS	$-0.780 ( Q1 \| 2024-05-03 )
Next earnings date	( $0.790 ) 2024-07-31
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-90.80 (Sector) 42.63 (Industry) 0
ATR14	$0.0500 (0.09%)

AEMD -9.77%

AFIB -12.68%

AHCO -2.70%

AHPI 0.00%

ALGN -1.16%

ANIK 2.05%

APEN 0.00%

APYX -2.99%

ARAY -3.30%

ATEC -4.50%

AXDX 0.00%

AXGN 6.49%

AXNX 0.10%

AZYO 2.05%

BBLG -2.44%

BIOL 7.80%

BJDX 0.87%

BMRA 0.07%

BRKR -2.32%

BSGM -0.06%

BWAY -3.46%

CERS -2.27%

CFMS 0.44%

CLPT -1.11%

CODX 0.80%

CSII 0.15%

CTKB 0.54%

CTSO -0.43%

CUTR -0.66%

CVRX -2.34%

DCTH -1.31%

DXCM -1.07%

DYNT -16.23%

EAR -4.10%

ECOR 0.00%

EDAP -4.04%

ESTA -4.62%

FONR 0.88%

HJLI -1.98%

HSDT -1.15%

HSKA 0.00%

HYPR 8.07%

IART -0.58%

ICAD -2.69%

ICCM -0.68%

IINN -11.59%

INGN -3.69%

INMD -2.03%

IRIX -3.24%

IRMD -1.14%

IRTC -1.11%

ISO 0.00%

ITMR 0.00%

KIDS -1.91%

LHDX 0.00%

LIVN -0.62%

LNSR -1.22%

LUCD -3.78%

LUNG -1.58%

MASS -7.38%

MDGS 10.28%

MOTS -16.81%

MOVE 5.78%

MSON 0.00%

NAOV -0.10%

NARI 4.24%

NMRD 33.33%

NNOX -2.59%

NPCE -3.17%

NTUS 0.00%

NURO -1.62%

NUVA -2.24%

NUWE -3.18%

NVCN 0.00%

NVNO -2.48%

OBLN -5.86%

OFIX -2.87%

OM -4.16%

PACB -12.41%

PAVM -6.26%

PETV -23.08%

PODD -2.79%

PRCT 1.28%

PROF 2.01%

QIPT -1.24%

QTRX -4.01%

RCEL -2.53%

RPID 3.05%

RSLS 3.86%

RWLK 6.07%

RXST -5.60%

SGHT -5.40%

SIBN -0.23%

SIEN -18.69%

SILK -0.33%

SINT -5.21%

SOLY 0.00%

SRDX -0.33%

SRGA 0.00%

SRTS -6.47%

SWAV 0.00%

TBIO 5.75%

TCMD -4.44%

TELA -4.47%

THMO -16.67%

TIVC -1.19%

TLIS -4.20%

TMCI -2.41%

TMDI 0.00%

TMDX -0.29%

TNDM -2.08%

TNON 18.05%

UFPT 9.56%

VERO -8.17%

VIVE 0.00%

VMD -2.29%

VRAY 0.00%

VREX -2.99%

VVOS 6.31%

XAIR 18.39%

XENT 0.00%

ZIMV -0.66%

Insider Trading

Date	Person	Action	Amount	type
2024-06-15	Barry James Christopher	Buy	3 416	Restricted Stock Units
2024-06-15	Wilver Peter M	Buy	2 680	Ordinary Shares
2024-06-15	Wilver Peter M	Sell	585	Ordinary Shares
2024-06-15	Wilver Peter M	Buy	3 416	Restricted Stock Units
2024-06-15	Wilver Peter M	Sell	2 680	Restricted Stock Units

INSIDER POWER
32.88
Last 100 transactions
Buy: 459 617 \| Sell: 228 913

Correlation (AI algo v.1.1b): Undervalued: 0.01% $54.49 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.06 (neutral)

Short: -0.94 (very strong negative)

Signal:(44.783) Neutral

LivaNova PLC Correlation

10 Most Positive Correlations
VCTR	0.852
SGMA	0.848
THCP	0.844
NTIC	0.842
ULBI	0.837
CBRG	0.836
HAS	0.834
UAL	0.831
APOG	0.827
PI	0.818

10 Most Negative Correlations
VRSN	-0.863
SYPR	-0.86
CRNC	-0.85
III	-0.84
VAXX	-0.836
HSDT	-0.835
XRAY	-0.831
CZR	-0.83
CVRX	-0.822
OPOF	-0.822

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

LivaNova PLC Correlation - Currency/Commodity

-0.06
( neutral )

-0.09
( neutral )

0.00
( neutral )

0.17
( neutral )

0.00
( neutral )

0.25
( neutral )

LivaNova PLC Financials

Annual	2023
Revenue:	$1.15B
Gross Profit:	$785.45M (68.09 %)
EPS:	$0.330

FY	2023
Revenue:	$1.15B
Gross Profit:	$785.45M (68.09 %)
EPS:	$0.330

FY	2022
Revenue:	$1.02B
Gross Profit:	$707.20M (69.21 %)
EPS:	$-1.610

FY	2021
Revenue:	$1.04B
Gross Profit:	$705.99M (68.19 %)
EPS:	$-2.68

Financial Reports:

No articles found.

LivaNova PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.